- Global Pharma News & Resources

Adam Andersen appointed Group Director of Pharma Portfolio at Informa

Andersen will oversee continued global expansion of pharma exhibitions including the global CPhI series and Pharmapack Europe


Amsterdam, 29th October 2018: Informa plc has appointed Adam Andersen Group Director of the Pharma Portfolio (previously part of UBM), which includes brands such as the global CPhI exhibition series – as well as co-located P-MEC, ICSE,  Innopack, FDF – bioLIVE and Pharmapack Europe.


Prior to his appointment Andersen headed Informa’s award-winning Natural Products Expos and SupplySide tradeshows. He brings a wealth of industry experience having spent more than 12 years with Informa’s New Hope Network, and Global Exhibitions division.


In the new role, Andersen will oversee the Pharma Portfolio (part of the Informa Health and Nutrition group) – including the recent CPhI Worldwide, which attracted nearly 45,000 visitors – bringing innovation and helping to integrate the pharma supply chain across new geographies.


Commenting on his appointment Andersen said: “I am excited to be driving these brands forward and continuing the great work of the talented teams in Amsterdam, and around the world, that contribute to make each CPhI event successful.  Events like CPhI Worldwide and Pharmapack are widely admired both within the pharma industry, where they deliver invaluable new contacts and partnerships, but also amongst the wider exhibitions sector. It’s a great privilege to lead this team and we will continue to focus on our customers to deliver greater success in the future.”


The pharma portfolio is headquartered in Amsterdam, Netherlands and oversees some of the world’s largest and most prominent pharma events in the United States, Europe, the Middle East and Asia. The portfolio serves the needs of more than 100,000 pharmaceutical professionals throughout the full pharma supply chain, with exhibitions and content platforms spanning discovery, development and commercialisation across small-molecules, bio, machinery, technology and drug devices and packaging.



Notes to editors


About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; BioPh for biopharma; and Finished Dosage Formulation for every aspect of the finished dosage supply chain.  CPhI provides an online buyer and supplier directory at

For more information visit


About Informa Exhibitions

Informa Exhibitions, the global exhibitions division of Informa PLC, enables communities across the globe to engage, experience and do business by providing them with powerful platforms to connect across key regions and market verticals. Industry insight, coupled with an innovative and customer first approach, provides Informa Exhibitions’ customers and partners with the opportunity to create business advantage and access markets, both digitally and face-to-face, 365 days of the year.


About Informa PLC

Informa PLC is a leading, international business to business information services Group, operating in over 30 countries. We create transaction-led exhibitions and content-based events, specialist data, intelligence and marketing services products, as well as scholarly research and specialist reference-led academic content. Our products and services help businesses and professionals connect, learn, do business and gain an edge over the competition. Informa is listed on the London Stock Exchange and is a member of the FTSE 100.




Editor Details

  • Name:
    • Informa
Last Updated: 30-Oct-2018